Clinical Cancer Genetics Program
The Clinical Cancer Genetics Program at M. D. Anderson Cancer Center is dedicated to providing hereditary cancer risk assessment and consultation services.
Approximately 5-10% of cancer is inherited. Individuals with a genetic predisposition will have a far higher chance of developing cancer within their lifetime and at an earlier age. Over the last 15-20 years, great progress has been made in identifying the genes responsible for a number of cancer susceptibility syndromes including hereditary breast and ovarian cancer (BRCA1 and BRCA2), Lynch syndrome (MLH1, MSH2, MSH6 and PMS2) and familial adenomatous polyposis (APC). Genetic tests can be used to confirm a suspected mutation in a cancer patient. The Clinical Cancer Genetics Program offers testing for identified gene mutations that are linked to inherited tendencies toward common cancers, including colon and breast cancer.
Our multidisciplinary team is comprised of specially trained genetic counselors and physicians who work together to provide education, hereditary cancer risk assessment, genetic counseling and genetic testing, individualized cancer screening and prevention programs to people who are concerned about their personal and family history of cancer.
News and Events
Miss our Conference on Hereditary Cancer Syndromes: Identifying and Managing your At-Risk Patients? Watch our new videos!